ADVERTISEMENT

Motilal Oswal: Biocon - Operational Challenges Impact Q2 Performance

Motilal Oswal: Biocon - Operational Challenges Impact Q2 Performance

A technician works at Biocon Ltd.’s cancer drug facility in Bangalore, India. (Photographer Namas Bhojani/Bloomberg)
A technician works at Biocon Ltd.’s cancer drug facility in Bangalore, India. (Photographer Namas Bhojani/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More